# Lonquek for Autologous Stem Cell Mobilization

> **NCT02488382** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 24 (estimated)

## Conditions studied

- Lymphoma
- Multiple Myeloma

## Interventions

- **DRUG:** Lonquek

## Key facts

- **NCT ID:** NCT02488382
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2018-07
- **Final completion:** 2020-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02488382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02488382, "Lonquek for Autologous Stem Cell Mobilization". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02488382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*